Imugene Ltd. is a biopharmaceutical company, which engages in the research, development, and commercialization of immunotherapies against cancer. Its products include b-cell peptide cancer vaccines, arginine modulators, and mimotopes. The company was founded on May 30, 1986 and is headquartered in Sydney, Australia.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
23
Frequently Asked Questions
What is Market Cap of Imugene Ltd.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Imugene Ltd. market cap is $131.65M.
What is the 52-week high for Imugene Ltd.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Imugene Ltd. 52 week high is $1.87 as of October 10, 2025.
What is the 52-week low for Imugene Ltd.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Imugene Ltd. 52 week low is $0.0101 as of October 10, 2025.
What is Imugene Ltd. stock price today?
Imugene Ltd. stock price today is $0.268.
What was Imugene Ltd. stock price yesterday?
Imugene Ltd. stock price yesterday was $0.293.
What is the PE ratio of Imugene Ltd.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Imugene Ltd.’s P/E ratio is -1.42.
What is the Price-to-Book ratio of Imugene Ltd.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Imugene Ltd. P/B ratio is 2.1808.
What is the 50-day moving average of Imugene Ltd.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Imugene Ltd. 50-day moving average is $0.1966.